WALTHAM, Mass., May 4, 2009 (GLOBE NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (XSSE:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, will report first quarter 2009 results on Monday, May 11, 2009. A conference call and webcast hosted by OXiGENE management will begin at 4:30 p.m. EDT (1:30 p.m. PDT).
